Cervical Cancer Survival Analysis in Eswatini, 2016-2024
by Sithembiso S. Msibi·Updated 2mo ago
221.4 KB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
2,349 cervical cancer patient records from the Eswatini Cancer Registry spanning 2016 to 2024, with 603 deaths analyzed. Sithembiso S. Msibi authored this first population-based survival analysis for cervical cancer in Eswatini, published on figshare in April 2026. The dataset likely contains clinical and demographic factors used to examine survival outcomes via Cox proportional hazards models.
Use Cases
Predicting survival outcomes based on cancer stage at diagnosis.
Analyzing the impact of HIV status on cervical cancer mortality.
Evaluating the effectiveness of treatments (chemotherapy, radiation, surgery) on hazard reduction.
Studying demographic factors like age and smoking status as potential confounders.
Modeling the association between treatment access and survival times.
Strengths
Includes 2,349 patient records, providing a substantial sample for analysis.
Contains detailed survival analysis results, including hazard ratios (HR: 0.70) and median survival times (10 months for Stage 4 vs. 40 months for Stage 1).
Covers a 8-year time range (2016-2024) from a national cancer registry.
Explicitly includes key clinical variables: cancer stage, age, smoking status, HIV status, treatment, and basis of diagnosis.
Limitations
Column-level documentation is absent; field semantics must be inferred after download.
Row count is unknown, which may limit suitability assessment.
The dataset is 221.4 KB, indicating a limited scope and likely aggregated summary data rather than raw patient-level records.
Provenance
Source
Eswatini Cancer Registry
Collection Method
Registry screening for cancer patients from 2016 to 2024.